Global Blood Plasma Market Size, Share Report, Analysis, Trends, Growth 2032

Blood Plasma Market

Blood Plasma Market Analysis By Distribution Channel (Ambulatory Surgical Centers, Hospitals, And Others), By Application (Coagulation Factor Deficiencies, Hemorrhage, Thrombotic Thrombocytopenic Purpura, Liver Disease, And Other Plasma Applications), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024-2032

Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-2959 Published Date: Oct-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 34.02 Billion USD 59.97 Billion 6.50% 2023

 

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Type
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Blood Plasma Market , 2015–2025 (USD Million)
    • 2.2. Blood Plasma Market : Snapshot
  • Chapter 3. Global Blood Plasma Market – Industry Analysis
    • 3.1. Blood Plasma Market : Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Rise in the health problems as a result of altering lifestyles, increase in the fund allocation to healthcare sector, and growing penetration of plasma-derived items in the healthcare industry will create lucrative growth avenues for the industry over the estimated timeline.
      • 3.2.2. A large number of benefits offered by blood plasma like coagulation of blood, defense, nutrition, maintaining of osmotic pressure, respiration, excretion, regulating of acid-base balance, and contrulling body temperature has transformed into huge market demand in the current years.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Application
      • 3.4.2. Market attractiveness analysis By Distribution Channel
  • Chapter 4. Global Blood Plasma Market – Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Blood Plasma Market : company market share, 2017
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Blood Plasma Market – Application Analysis
    • 5.1. Global Blood Plasma Market overview: By Application
      • 5.1.1. Global Blood Plasma Market share, By Application, 2018 and 2025
    • 5.2. Coagulation factor deficiencies
      • 5.2.1. Global Blood Plasma Market By Coagulation factor deficiencies, 2015–2025 (USD Million)
    • 5.3. Thrombotic thrombocytopenic purpura
      • 5.3.1. Global Blood Plasma Market By Thrombotic thrombocytopenic purpura, 2015–2025 (USD Million)
    • 5.4. Hemorrhage
      • 5.4.1. Global Blood Plasma Market By Hemorrhage, 2015–2025 (USD Million)
    • 5.5. Liver disease
      • 5.5.1. Global Blood Plasma Market By Liver disease, 2015–2025 (USD Million)
    • 5.6. Other plasma applications
      • 5.6.1. Global Blood Plasma Market By Other plasma applications, 2015–2025 (USD Million)
  • Chapter 6. Global Blood Plasma Market – Distribution Channel Analysis
    • 6.1. Global Blood Plasma Market overview: By Distribution Channel
      • 6.1.1. Global Blood Plasma Market share, By Distribution Channel , 2018 and 2025
    • 6.2. Hospitals
      • 6.2.1. Global Blood Plasma Market By Hospitals, 2015–2025 (USD Million)
    • 6.3. Ambulatory Surgical Centers
      • 6.3.1. Global Blood Plasma Market By Ambulatory Surgical Centers, 2015–2025 (USD Million)
    • 6.4. Others
      • 6.4.1. Global Blood Plasma Market By Others, 2015–2025 (USD Million)
  • Chapter 7. Company Profiles
    • 7.1. Medivators Inc. (Cantel Medical Corp.)
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Product Portfolio
      • 7.1.4. Business Strategy
      • 7.1.5. Recent Developments
    • 7.2. Olympus Corporation
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Product Portfolio
      • 7.2.4. Business Strategy
      • 7.2.5. Recent Developments
    • 7.3. STERIS Plc.
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Product Portfolio
      • 7.3.4. Business Strategy
      • 7.3.5. Recent Developments
    • 7.4. Getinge Group
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Product Portfolio
      • 7.4.4. Business Strategy
      • 7.4.5. Recent Developments
    • 7.5. Steelco S.P.A
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Product Portfolio
      • 7.5.4. Business Strategy
      • 7.5.5. Recent Development
    • 7.6. Belimed AG (Metall Zug)
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Product Portfolio
      • 7.6.4. Business Strategy
      • 7.6.5. Recent Development
    • 7.7. F. Hoffmann-La Roche Ltd
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Product Portfolio
      • 7.7.4. Business Strategy
      • 7.7.5. Recent Development
    • 7.8. Pfizer Inc.
      • 7.8.1. Overview
      • 7.8.2. Financials
      • 7.8.3. Product Portfolio
      • 7.8.4. Business Strategy
      • 7.8.5. Recent Development
    • 7.9. Advanced Sterilization Products Services Inc. (Johnson & Johnson)
      • 7.9.1. Overview
      • 7.9.2. Financials
      • 7.9.3. Product Portfolio
      • 7.9.4. Business Strategy
      • 7.9.5. Recent Development
    • 7.10. Merck & Co., Inc.
      • 7.10.1. Overview
      • 7.10.2. Financials
      • 7.10.3. Product Portfolio
      • 7.10.4. Business Strategy
      • 7.10.5. Recent Development
    • 7.11. Bayer AG
      • 7.11.1. Overview
      • 7.11.2. Financials
      • 7.11.3. Product Portfolio
      • 7.11.4. Business Strategy
      • 7.11.5. Recent Development
    • 7.12. Abbott Laboratories
      • 7.12.1. Overview
      • 7.12.2. Financials
      • 7.12.3. Product Portfolio
      • 7.12.4. Business Strategy
      • 7.12.5. Recent Development
    • 7.13. Dickinson and Company
      • 7.13.1. Overview
      • 7.13.2. Financials
      • 7.13.3. Product Portfolio
      • 7.13.4. Business Strategy
      • 7.13.5. Recent Development
    • 7.14. Alere Inc.
      • 7.14.1. Overview
      • 7.14.2. Financials
      • 7.14.3. Product Portfolio
      • 7.14.4. Business Strategy
      • 7.14.5. Recent Development
    • 7.15. Cantel Medical Corp.
      • 7.15.1. Overview
      • 7.15.2. Financials
      • 7.15.3. Product Portfolio
      • 7.15.4. Business Strategy
      • 7.15.5. Recent Development
    • 7.16. Bemis Company
      • 7.16.1. Overview
      • 7.16.2. Financials
      • 7.16.3. Product Portfolio
      • 7.16.4. Business Strategy
      • 7.16.5. Recent Development
    • 7.17. Crosstex International, Inc.
      • 7.17.1. Overview
      • 7.17.2. Financials
      • 7.17.3. Product Portfolio
      • 7.17.4. Business Strategy
      • 7.17.5. Recent Development
    • 7.18. Covidien plc
      • 7.18.1. Overview
      • 7.18.2. Financials
      • 7.18.3. Product Portfolio
      • 7.18.4. Business Strategy
      • 7.18.5. Recent Development
    • 7.19. Diversey, Inc
      • 7.19.1. Overview
      • 7.19.2. Financials
      • 7.19.3. Product Portfolio
      • 7.19.4. Business Strategy
      • 7.19.5. Recent Development
    • 7.20. Danaher Corp.
      • 7.20.1. Overview
      • 7.20.2. Financials
      • 7.20.3. Product Portfolio
      • 7.20.4. Business Strategy
      • 7.20.5. Recent Development
    • 7.21. MMM Group
      • 7.21.1. Overview
      • 7.21.2. Financials
      • 7.21.3. Product Portfolio
      • 7.21.4. Business Strategy
      • 7.21.5. Recent Development
    • 7.22. Getinge Group
      • 7.22.1. Overview
      • 7.22.2. Financials
      • 7.22.3. Product Portfolio
      • 7.22.4. Business Strategy
      • 7.22.5. Recent Development
    • 7.23. Sealed Air Corp
      • 7.23.1. Overview
      • 7.23.2. Financials
      • 7.23.3. Product Portfolio
      • 7.23.4. Business Strategy
      • 7.23.5. Recent Development
    • 7.24. Purdue Pharma LP
      • 7.24.1. Overview
      • 7.24.2. Financials
      • 7.24.3. Product Portfolio
      • 7.24.4. Business Strategy
      • 7.24.5. Recent Development
    • 7.25. Synergy Health plc
      • 7.25.1. Overview
      • 7.25.2. Financials
      • 7.25.3. Product Portfolio
      • 7.25.4. Business Strategy
      • 7.25.5. Recent Development
    • 7.26. Semperit AG Hulding
      • 7.26.1. Overview
      • 7.26.2. Financials
      • 7.26.3. Product Portfolio
      • 7.26.4. Business Strategy
      • 7.26.5. Recent Development

Table Of Figures

List of Figures

1. Market research Type
2. Market research methodology
3. Global Blood Plasma Market , 2015–2025 (USD Million)
4. Porter’s Five Forces Analysis
5. Global Blood Plasma Market  attractiveness, By Application  
6. Global Blood Plasma Market  attractiveness, By Distribution Channel  
7. Global Blood Plasma Market  share by Application ,2018 and 2025 (USD Million)
8. Global Blood Plasma Market  By Coagulation factor deficiencies,2015–2025 (USD Million)
9. Global Blood Plasma Market  By Thrombotic thrombocytopenic purpura ,2015–2025 (USD Million)
10. Global Blood Plasma Market  By Hemorrhage ,2015–2025 (USD Million)
11. Global Blood Plasma Market  By Liver disease ,2015–2025 (USD Million)
12. Global Blood Plasma Market  By Other plasma applications ,2015–2025 (USD Million)
13. Global Blood Plasma Market  share by Distribution Channel, 2018 and 2025 (USD Million)
14. Global Blood Plasma Market  By Hospitals,2015–2025 (USD Million)
15. Global Blood Plasma Market  By Ambulatory Surgical Centers ,2015–2025 (USD Million)
16. Global Blood Plasma Market  By Environmental Biosciences ,2015–2025 (USD Million)
17. Global Blood Plasma Market  By Others ,2015–2025 (USD Million)
18. Global Blood Plasma Market  share, by Region, 2018 and 2025
19. North America Blood Plasma Market , 2015–2025 (USD Million)
20. Europe Blood Plasma Market , 2015–2025 (USD Million)
21. Asia Pacific Blood Plasma Market , 2015–2025 (USD Million)
22. Latin America Blood Plasma Market , 2015–2025 (USD Million)
23. The Middle East and Africa Blood Plasma Market , 2015–2025 (USD Million)
 


Table Of Tables

List of Tables

1. Global Blood Plasma Market : snapshot
2. Drivers of the Blood Plasma Market : impact analysis
3. North America Blood Plasma Market  revenue, By Application   , 2015–2025 (USD Million)
4. North America Blood Plasma Market  revenue, By Distribution Channel  , 2015–2025 (USD Million)
5. The U.S. Blood Plasma Market  revenue, By Application    , 2015–2025 (USD Million)
6. The U.S. Blood Plasma Market  revenue, By Distribution Channel  , 2015–2025 (USD Million)
7. Rest of North America Blood Plasma Market  revenue, By Application    , 2015–2025 (USD Million)
8. Rest of North America Blood Plasma Market  revenue, By Distribution Channel  , 2015–2025 (USD Million)
9. Europe Blood Plasma Market  revenue, By Application    , 2015–2025 (USD Million)
10. Europe Blood Plasma Market  revenue, By Distribution Channel  , 2015–2025 (USD Million)
11. UK Blood Plasma Market  revenue, By Application    , 2015–2025 (USD Million)
12. UK Blood Plasma Market  revenue, By Distribution Channel  , 2015–2025 (USD Million)
13. France Blood Plasma Market  revenue, By Application    , 2015–2025 (USD Million)
14. France Blood Plasma Market  revenue, By Distribution Channel  , 2015–2025 (USD Million)
15. Germany Blood Plasma Market  revenue, By Application    , 2015–2025 (USD Million)
16. Germany Blood Plasma Market  revenue, By Distribution Channel  , 2015–2025 (USD Million)
17. Rest of Europe Blood Plasma Market  revenue, By Application    , 2015–2025 (USD Million)
18. Rest of Europe Blood Plasma Market  revenue, By Distribution Channel  , 2015–2025 (USD Million)
19. Asia Pacific Blood Plasma Market  revenue, By Application    , 2015–2025 (USD Million)
20. Asia Pacific Blood Plasma Market  revenue, By Distribution Channel  , 2015–2025 (USD Million)
21. China Blood Plasma Market  revenue, By Application    , 2015–2025 (USD Million)
22. China Blood Plasma Market  revenue, By Distribution Channel  , 2015–2025 (USD Million)
23. Japan Blood Plasma Market  revenue, By Application    , 2015–2025 (USD Million)
24. Japan Blood Plasma Market  revenue, By Distribution Channel  , 2015–2025 (USD Million)
25. India Blood Plasma Market  revenue, By Application    , 2015–2025 (USD Million)
26. India Blood Plasma Market  revenue, By Distribution Channel  , 2015–2025 (USD Million)
27. Rest of Asia Pacific Blood Plasma Market  revenue, By Application    , 2015–2025 (USD Million)
28. Rest of Asia Pacific Blood Plasma Market  revenue, By Distribution Channel  , 2015–2025 (USD Million)
29. Latin America Blood Plasma Market  revenue, By Application    , 2015–2025 (USD Million)
30. Latin America Blood Plasma Market  revenue, By Distribution Channel  , 2015–2025 (USD Million)
31. Brazil Blood Plasma Market  revenue, By Application    , 2015–2025 (USD Million)
32. Brazil Blood Plasma Market  revenue, By Distribution Channel  , 2015–2025 (USD Million)
33. Rest of Latin America Blood Plasma Market  revenue, By Application    , 2015–2025 (USD Million)
34. Rest of Latin America Blood Plasma Market  revenue, By Distribution Channel  , 2015–2025 (USD Million)
35. The Middle East and Africa Blood Plasma Market  revenue, By Application    , 2015–2025 (USD Million)
36. The Middle East and Africa Blood Plasma Market  revenue, By Distribution Channel  , 2015–2025 (USD Million)
37. Saudi Arabia Blood Plasma Market  revenue, By Application    , 2015–2025 (USD Million)
38. Saudi Arabia Blood Plasma Market  revenue, By Distribution Channel  , 2015–2025 (USD Million)
39. South Africa Blood Plasma Market  revenue, By Application    , 2015–2025 (USD Million)
40. South Africa Blood Plasma Market  revenue, By Distribution Channel  , 2015–2025 (USD Million)
41. Rest of the Middle East & Africa Blood Plasma Market  revenue, By Application    , 2015–2025 (USD Million)
42. Rest of the Middle East & Africa Blood Plasma Market  revenue, By Distribution Channel   , 2015–2025 (USD Million)

 
 

Methodology

FrequentlyAsked Questions

Blood plasma is the liquid component of blood containing proteins and antibodies. It is used in medical therapies and pharmaceuticals
The global Global Blood Plasma market is expected to be driven by the rising demand for plasma-derived therapies and increasing diagnosis of immune and rare diseases. Growth in biopharmaceutical manufacturing supports market expansion.
According to study, the global Global Blood Plasma market size was worth around USD 34.02 Billion in 2023 and is predicted to grow to around USD 59.97 Billion By 2032.
The global Global Blood Plasma market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 6.50% during the forecast period from 2024-2032.
The global Global Blood Plasma industry is projected to be challenged by Challenges include donor shortages, complex collection logistics, and strict regulatory compliance.
The Opportunities include rising demand for plasma-derived therapies, growth in immunology treatments, aging population needs, and capacity expansion in emerging markets will offer significant growth opportunities in the Global Blood Plasma market.
Expansion of plasma collection networks; advanced fractionation and purification; growing demand for immunoglobulins and rare disease therapies are the emerging trends and innovations impacting the Global Blood Plasma market.
The global Global Blood Plasma market is expected to be led by North America during the forecast period.
Some of the prominent players operating in the global Global Blood Plasma market are; Grifols S.A., Kedrion S.p.A., Octopharma AG, Baxter International Inc., CSL Ltd., Biotest AG, Shire, China Biologic Products, and Sanquin. and others.
The report explores crucial aspects of the Global Blood Plasma market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
  • zion payment modes

List of Contents

Industry PerspectiveMarket OverviewGrowth DriversReport ScopeRegional InsightsCompetitive Space

HappyClients